home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Hope For Muscular Dystrophy Gene Therapy

  September, 25 2001 0:20
your information resource in human molecular genetics
A possible strategy for gene therapy in patients with the most severe form of the muscle-wasting condition congenital muscular dystrophy (MCMD) is reported in this week’s Nature (Vol. 413, No. 6853, 20 Sep 2001).

In a mouse model of the disease, Markus A. Ruegg of the University of Basel, Switzerland, and colleagues, remedied the lack of a muscle scaffold protein with a specially engineered miniature form (miniagrin) of another muscle protein (agrin) featuring only that protein’s functional regions.

That the technique restored the rodents’ muscle function suggests that drugs to raise agrin levels might alleviate symptoms of muscular dystrophy. It also demonstrates how small versions of large proteins can be useful for gene therapy, especially as they are "less likely to cause immunological responses," as Ruegg’s team points out.


Markus A. Ruegg
tel +41 61 267 22 23
e-mail markus-a.ruegg@unibas.ch

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.